CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Compare Roth and Traditional withdrawal strategies in retirement to optimize cash flow and tax efficiency across decades.
18,537 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
MetaMask rolled out an AI Agent Wallet on June 8, 2026, enabling autonomous trading across Ethereum. The move could i...
A sharp-eyed retail manager noticed odd behavior at checkout and intervened, saving an elderly customer from a $1,000...
Anthropic's best ever model claude projects XRP climbing to 4.50 by late 2026, signaling a potential fourfold rally a...
Chevron’s finance chief Eimear Bonner outlines how finance leaders are shaping AI value at the oil giant, turning tec...
SpaceX is exploring a historic mega-IPO with a razor-thin gross spread. Goldman leads a bid to win the deal at one of...
Arm Holdings faces macro headwinds as the Fed signals restraint. Investors are weighing a buy, hold, sell: holdings f...
Bitcoin holds near $64,000 as ADA targets a comeback this weekend, amid inflation jitters and geopolitical tensions s...
Bitcoin rose past $65,000 on Monday as reports of a potential U.S.-Iran peace agreement eased geopolitical fears. Ana...
UFC boss Dana White says the White House fight night was a costly one-off that won’t be repeated. This report breaks ...
Dallas-Fort Worth is seeing a growth shift to the south, as new toll corridors and job centers spur homebuilding and ...
The nuclear energy story 2026 is taking shape as decarbonization and power-hungry data demand push expansion. This gu...